Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Filter By:

Search by Keyword (disease, investigator, treatment name):

An Open-Label Phase Ib/II Study of Surufatinib in Combination with Tislelizumab in Subjects with Advanced Solid Tumors

Multiple Cancer Types

Disease Sites: Miscellaneous, Phase I

Phase: I/II

Investigator: Das, Satya

NCTID: NCT04579757

Protocol No: VICCPHI20125

A Phase 2 Study to Evaluate the Efficacy and Safety of Belzutifan (MK-6482, formerly PT2977) Monotherapy in Participants with Advanced Pheochromocytoma/Paraganglioma (PPGL) or Pancreatic Neuroendocrine Tumor (pNET).

Multiple Cancer Types

Disease Sites: Endocrine, Pancreatic

Phase: II

Investigator: Das, Satya

NCTID: NCT04924075

Protocol No: VICCMD2132

A phase 1 study of TJ033721 in subjects with advanced or metastatic solid tumors.

Phase I

Disease Sites: Phase I

Phase: I

Investigator: Das, Satya

NCTID: NCT04900818

Protocol No: VICCPHI2151

Platinum/Etoposide with or without Atezolizumab (NSC#783608) in Patients with Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC)

Neuroendocrine

Disease Sites: Neuroendocrine

Phase: II/III

Investigator: Das, Satya

NCTID: NCT05058651

Protocol No: SWOGGIS2012

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)